Mexican Pharmaceutical Forum
Mexican Pharmaceutical Forum
  • Languages
  • Home
  • About us
  • Venue
  • Programme
  • Speakers
  • Suggest a speaker
  • Networking
  • Mexican Pharma Awards
    • About the Awards
    • Application for the nomination
  • Sponsorship
  • News
  • Contact us
  • Languages
  • Home
  • About us
  • Venue
  • Programme
  • Speakers
  • Suggest a speaker
  • Networking
  • Mexican Pharma Awards
    • About the Awards
    • Application for the nomination
  • Sponsorship
  • News
  • Contact us
MEXICO: +52 558 526-60-31
UK:
+44 204 577-36-57
mexico@iventu.co.uk
45 Fitzroy Street, Fitzrovia London, W1T 6EB, United Kingdom
Mexican Pharmaceutical Forum
Mexican Pharmaceutical Forum


Footer – Español

Continue Reading

Footer

Continue Reading


Bayer will invest 350 million euros in Mexico but asks for better regulation

0August 10, 20220

Alerta Cofepris robo de medicamentos y equipo para hemodiálisis

0July 22, 20220

Investing in Cannabis is safe for economic growth in Mexico: Industry Experts

0August 1, 20220

Solo Salud will supply anti-Covid drugs excluding the private sector

0August 23, 20220

Laboratorios clínicos de México fortalecen estrategias para desarrollo y acceso a medicamentos

0August 4, 20220

AMELAF AMELAF AMLO AMLO Bayer Bayer Becton Dickinson Becton Dickinson CANIFARMA CANIFARMA Cannabis Cannabis COFEPRIS COFEPRIS Concamin Concamin counterfeit drugs COVAX COVID-19 COVID-19 Edomex Edomex Estados Unidos falsificación de medicamentos INEGI INEGI INSABI INSABI Latin America Latinoamérica Monkeypox Neolpharma Neolpharma Novartis Novartis Mexico SFP T-MEC UNEFARM UNEFARM UNOPS UNOPS US Vaccines Vacunas Viruela del mono

Global Pharmaceutical Leaders' Club

45 Fitzroy Street, Fitzrovia
London, W1T 6EB, United Kingdom

MEXICO +52 558 526-60-31
UK+44 204 577-36-57
Send your inquiry

© 2024 Global Pharmaceutical Leaders' Club Ltd. All rights reserved | Privacy Policy | Terms and Conditions | FAQ